Skip to content

To compare and see the effect of Ayurvedic formulation Karanj bark lepa and Karanj seed oil in the management of Vicharchika with respect to eczema.

A Pilot study to compare Pharmacognostic phytochemical and Therapeutical effects of Karanj bark lepa and Karanj seed oil in the management of Vicharchka W S R to Eczema - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071379
Enrollment
14
Registered
2024-07-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

None listed

Sponsors

Institute for Ayurved Studies and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Individuals willingly ready to follow the procedure. 2.Patients with sign and symptoms of Vicharahika w.s.r.eczema. 3.Patients from age group of 16-70 years will be selected.

Exclusion criteria

Exclusion criteria: 1. Below the age of 16 yrs and above 70 yr. 2. Patient having concomitant illness like DM, AIDS, auto immune disorders. 3. Patient with evidence of any malignancy. 4. Any drug addiction and drugs reactions. 5. Patient having illness like Scabies, Psoriasis, Leucoderma and diagnosis chronic illnesss.

Design outcomes

Primary

MeasureTime frame
Reduced EASI score.Timepoint: Reduced EASI score after treatment period of 30 days

Secondary

MeasureTime frame
1 Changes in affected lesion s colour 2 Changes in the Subjective Parameter that are pruritis Burning Oozing Dryness Eruption Discolouration Thickning of skin Timepoint: follow Up will be done after 7th 14th 21st & 30th trial & post assessment will be done on 30th day on the basis of parameters

Countries

India

Contacts

Public ContactNarendra Mehta

Institute for Ayurved Studies and Research Kurukshetra Haryana

satyender70@gmail.com9665026320

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026